Stock Research for SNY

Current Price

$39.9350


Latest Update: 2018-02-16 16:00:00

High
$ 39.9400
Low
$ 39.9100
Close
$ 39.9100
Volume
24232
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

SNY Stock Chart & Research Data

The SNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SNY Due diligence Resources & Stock Charts

The SNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SNY Detailed Price Forecast - CNN Money CNN View SNY Detailed Summary - Google Finance
Yahoo View SNY Detailed Summary - Yahoo! Finance Zacks View SNY Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SNY Trends & Analysis - Trade-Ideas Barrons View SNY Major Holders - Barrons
NASDAQ View SNY Call Transcripts - NASDAQ Seeking View SNY Breaking News & Analysis - Seeking Alpha
Spotlight View SNY Annual Report - CompanySpotlight.com OTC Report View SNY OTC Short Report - OTCShortReport.com
TradeKing View SNY Fundamentals - TradeKing Charts View SNY SEC Filings - Bar Chart
WSJ View Historical Prices for SNY - The WSJ Morningstar View Performance/Total Return for SNY - Morningstar
MarketWatch View the Analyst Estimates for SNY - MarketWatch CNBC View the Earnings History for SNY - CNBC
StockMarketWatch View the SNY Earnings - StockMarketWatch MacroAxis View SNY Buy or Sell Recommendations - MacroAxis
Bullish View the SNY Bullish Patterns - American Bulls Short Pains View SNY Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SNY Stock Mentions - StockTwits PennyStocks View SNY Stock Mentions - PennyStockTweets
Twitter View SNY Stock Mentions - Twitter Invest Hub View SNY Investment Forum News - Investor Hub
Yahoo View SNY Stock Mentions - Yahoo! Message Board Seeking Alpha View SNY Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for SNY - SECform4.com Insider Cow View Insider Transactions for SNY - Insider Cow
CNBC View SNY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SNY - OTC Markets
Yahoo View Insider Transactions for SNY - Yahoo! Finance NASDAQ View Institutional Holdings for SNY - NASDAQ


Stock Charts

FinViz View SNY Stock Insight & Charts - FinViz.com StockCharts View SNY Investment Charts - StockCharts.com
BarChart View SNY Stock Overview & Charts - BarChart Trading View View SNY User Generated Charts - Trading View


Latest Financial News for SNY

Why 2018 Could Be An Explosive Year For Biotech Mergers
Posted on Friday February 16, 2018

This year could be big for biotech mergers after Celgene and Sanofi, in a few days, spent $25 billion for three companies.


Healthcare Stocks In The News Last Week
Posted on Friday February 16, 2018

believe that many investors under-appreciate Sanofi’s non-diabetes businesses and think that the strength from the rest of the company will provide plenty of opportunity for upside, including the new acquisitions and pipeline. The recent slide in shares makes SNY an attractive purchase in our eyes.


Why Teva Pharmaceutical Stock Soared More than 10% on Thursday
Posted on Friday February 16, 2018

On February 15, 2018, Teva Pharmaceutical (TEVA) stock registered a rise of ~10.5% in pre-market trading on the disclosure of Berkshire Hathaway’s (BRK) investment of $358 million in the stock at the end of 4Q17. Berkshire Hathaway’s investment in Teva bodes well for Teva investors. Given that Berkshire Hathaway’s investments are based on founder Warren Buffet’s value investing strategy, Teva is now seen as a fundamental value investment.


Could Novavax, Inc. Be a Millionaire-Maker Stock?
Posted on Friday February 16, 2018

Novavax is hot right now -- but just how much hotter could this biotech stock get?


5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now
Investorplace.com - Apr 12, 2017
Paris, France based Sanofi SA (ADR) (NYSE:SNY) is a global healthcare company possessing a diversified product portfolio.

Biotech M&A: Sanofi SA (ADR) Inks 2nd Multi-Billion Dollar Deal in a Week
Investorplace.com - Jan 29, 2018
ABLYNX specializes in the research of novel drugs based on nanobodies found in the immune systems of llamas and alpacas, for which it partners with several of the world's largest pharmaceutical companies.
Sanofi SA (ADR) (NYSE:SNY) Acquires Ablynx NV in Equity Value of $4.85 billion - Benchmark Monitor
Sanofi Announces Second Billion-Dollar Deal In a Week, and It May Not Be Done - TheStreet.com

Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma
Investorplace.com - Dec 9, 2016
The biggest move that's underway is that Sanofi intends to sell its generics business. Not only will that mean a big inflow of cash, but it will also mean SNY stock will be increasingly aggressive in finding new acquisition targets.

Sanofi SA (ADR): SNY Pipeline Is Overflowing With Potential
Investorplace.com - Apr 14, 2016
France-based Sanofi SA (ADR) (SNY) is one of the world's largest pharmaceutical companies. I mentioned where it's headquartered because the company actually pre-dates much of America.

Enter a stock symbol to view the stock details.